Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RA BIODAM biomarker validation study in rheumatoid arthritis
NL-OMON35219Active, not recruiting
- Sponsor
- CARE Arthritis
- Start
- Mar 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of methotrexate, 5-aminosalicylic acid + sulphasalazine, hydroxychloroquine, chloroquine, leflunomide and 5 more, sponsored by CARE Arthritis. Started Mar 2012; status: active, not recruiting.
02
Drugs
methotrexate5-aminosalicylic acid + sulphasalazinehydroxychloroquinechloroquineleflunomide
Beyond the preview
Go deeper on NL-OMON35219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35219.